Measurement properties of quality-of-life outcome measures for children and adults with eczema: An updated systematic review.
atopic dermatitis
eczema
measurement properties
patient-reported outcome measures
quality of life
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
02
07
2019
revised:
05
08
2019
accepted:
22
08
2019
pubmed:
11
9
2019
medline:
15
12
2020
entrez:
11
9
2019
Statut:
ppublish
Résumé
The aim of this updated systematic review was to systematically assess the measurement properties of previously discussed and new quality-of-life patient-reported outcome measures (PROMs) in children and adults with eczema using the new COSMIN guideline. A systematic literature search was conducted in PubMed and EMBASE. Eligible studies reported on measurement properties of quality-of-life PROMs for children and adults with eczema. The methodological quality of selected already known PROMs and new evidence identified through the literature search was assessed with the COSMIN Risk of Bias checklist. The adequacy of included PROMs was judged with updated quality criteria, and the quality of evidence of the summarized results was graded. Finally, PROMs were placed in a recommendation category (A-C). In total, 133 measurement properties of nine different PROMs were assessed. No PROM could be placed in category A due to a lack of validation studies. Only the DLQI fulfilled the criteria for category C and therefore should not be recommended for use. All other PROMs were placed in category B, that is, they still have the opportunity to be recommended, but need further validation. Currently, no PROM for quality of life can be recommended for use in children and adults with eczema. Further validation is needed. The DLQI cannot be recommended for future use.
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
66-77Informations de copyright
© 2019 The Authors. Pediatric Allergy and Immunology published by John Wiley & Sons Ltd.
Références
Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351.
Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26-30.
Schmitt J, Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67(9):1111-1117.
Marshall S, Haywood K, Fitzpatrick R. Impact of patient-reported outcome measures on routine practice: a structured review. J Eval Clin Pract. 2006;12(5):559-568.
Heinl D, Prinsen CA, Deckert S, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review. Allergy. 2016;71(3):358-370.
Heinl D, Prinsen C, Sach T, et al. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review. Br J Dermatol. 2017;176(4):878-889.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality Life Res: Int J Quality Life Aspects Treatment Care Rehab. 2010;19(4):539-549.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737-745.
Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Quality Life Res: Int J Quality Life Aspects Treatment Care Rehab. 2012;21(4):651-657.
Schmitt J, Langan S, Deckert S, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337-1347.
Mokkink LB, de Vet H, Prinsen C, COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Quality Life Res: Int J Quality Life Aspects Treatment Care Rehab. 2018;27(5):1171-1179.
Prinsen C, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Quality Life Res. 2018;27(5):1147-1157.
Heinl D, Prinsen CA, Drucker AM, et al. Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review. Syst Rev. 2016;5:25.
Apfelbacher CJ, Heinl D, Prinsen CA, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review. Syst Rev. 2015;4:48.
Schafer T, Staudt A, Ring J. [German instrument for the assessment of quality of life in skin diseases (DIELH). Internal consistency, reliability, convergent and discriminant validity and responsiveness]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2001;52(7):624-628.
Schafer T, Staudt A, Ring J. [Development of the German scale for assessing quality of life in skin diseases]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2001;52(6):492-498.
Augustin M, Lange S, Wenninger K, Seidenglanz K, Amon U, Zschocke I Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol: EJD. 2004;14(2):107-113.
Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U. [Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1999;50(10):715-722.
Evers AW, Duller P, van de Kerkhof PC, et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol. 2008;158(1):101-108.
Chalmers JR, Simpson E, Apfelbacher CJ, et al. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol. 2016;175(1):69-79.
Whalley D, McKenna SP, Dewar AL, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol. 2004;150(2):274-283.
McKenna SP, Doward LC, Meads DM, Tennant A, Lawton G, Grueger J. Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials. Health Qual Life Outcomes. 2007;5:45.
Terwee CB, Prinsen CA, Chiarotto A, et al. COSMIN methodology for assessing the content validity of Patient-Reported Outcome Measures (PROMs). User manual. 2017.
Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42.
Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN methodology for systematic reviews of Patient-Reported Outcome. Measures (PROMs) - user manual. 2018.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med: Peer-Reviewed Independent Open-Access J. 2009;3(3):e123-e130.
Alzolibani AA. Cultural adaptation of the Arabic version of the Infants' Dermatitis Quality of Life Index. Saudi Med J. 2013;34(5):518-524.
Alzolibani AA. Impact of atopic dermatitis on the quality of life of Saudi children. Saudi Med J. 2014;35(4):391-396.
Baranzoni NS, Mantovani LG, De Portu S, Monzini MS, Giannetti A. Validation of the Italian version of the Infants Dermatitis Quality of Life and Family Dermatitis Indexes. Giornale Italiano di Dermatologia e vererologia. 2007;142:423-432.
Beattie PE, Lewis-Jones MS. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score. Br J Dermatol. 2006;155(6):1249-1255.
Boccardi D, D'Auria E, Turati F, et al. Disease severity and quality of life in children with atopic dermatitis: PO-SCORAD in clinical practice. Minerva Pediatr. 2017;69(5):373-380.
Ganemo A, Svensson A, Lindberg M, Wahlgren CF. Quality of life in Swedish children with eczema. Acta dermato-venereologica. 2007;87(4):345-349.
Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants' Dermatitis Quality of Life Index. Br J Dermatol. 2001;144(1):104-110.
Raznatovic Djurovic M, Jankovic J, Tomic Spiric V, Jankovic S. Health-related Quality of Life in Children with Moderate to Severe Atopic Dermatitis. Acta dermatovenerologica Croatica: ADC. 2015;23(3):178-184.
van Valburg RW, Willemsen MG, Dirven-Meijer PC, Oranje AP, van der Wouden JC, Moed H. Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice. Acta dermato-venereologica. 2011;91(2):147-151.
Aziah MS, Rosnah T, Mardziah A, Norzila MZ. Childhood atopic dermatitis: a measurement of quality of life and family impact. Med J Malaysia. 2002;57(3):329-339.
Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol. 2006;154(4):719-725.
Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-949.
Maksimovic N, Jankovic S, Marinkovic J, Sekulovic LK, Zivkovic Z, Spiric VT. Health-related quality of life in patients with atopic dermatitis. J Dermatol. 2012;39(1):42-47.
Ramirez-Anaya M, Macias ME, Velazquez-Gonzalez E. Validation of a Mexican Spanish version of the Children's Dermatology Life Quality Index. Pediatric Dermatol. 2010;27(2):143-147.
Chamlin SL, Cella D, Frieden IJ, et al. Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol. 2005;125(6):1106-1111.
Chamlin SL, Frieden IJ, Williams ML, Chren M-M. Effects of atopic dermatitis on young American children and their families. Pediatrics. 2004;114(3):607-611.
Chamlin SL, Lai JS, Cella D, et al. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol. 2007;143(6):768-772.
Neri E, Agostini F, Gremigni P, et al. Italian validation of the Childhood Atopic Dermatitis Impact Scale: a contribution to its clinical application. J Invest Dermatol. 2012;132(11):2534-2543.
Yamaguchi C, Futamura M, Chamlin SL, Ohya Y, Asano M. Development of a Japanese Culturally Modified Version of the Childhood Atopic Dermatitis Impact Scale (JCMV-CADIS). Allergology Int. 2016;65(3):312-319.
Baars RM, Atherton CI, Koopman HM, Bullinger M, Power M. The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents. Health Qual Life Outcomes. 2005;3(1):70.
Deon KC, Santos DM, Bullinger M, Santos CB. Preliminary psycometric assessment of the Brazilian version of the DISABKIDS Atopic Dermatitis Module. Rev Saude Publica. 2011;45(6):1072-1078.
Chernyshov PV, Boffa MJ, Corso R, et al. Creation and pilot test results of the dermatology-specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life. J Eur Acad Dermatol Venereol. 2018;32(12):2288-2294.
Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol. 1999;141(4):698-702.
Chernyshov PV. Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia. 2016;151(1):37-43.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216.
Herd RM, Tidman MJ, Ruta DA, Hunter JA. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol. 1997;136(4):502-507.
Liu Y, Li T, An J, Zeng W, Xiao S. Rasch analysis holds no brief for the use of the Dermatology Life Quality Index (DLQI) in Chinese neurodermatitis patients. Health Qual Life Outcomes. 2016;14:17.
Patel KR, Singam V, Vakharia PP, et al. Measurement properties of three assessments of burden used in atopic dermatitis in adults. Br J Dermatol. 2019;180(5):1083-1089.
Twiss J, Meads DM, Preston EP, Crawford SR, McKenna SP. Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol. 2012;132(1):76-84.
Augustin M, Wenninger K, Amon U, et al. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology (Basel, Switzerland). 2004;209(1):14-20.
Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433-1440.
He Z, Lu C, Chren MM, et al. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes. 2014;12:190.
Taieb A, Boralevi F, Seneschal J, et al. Atopic dermatitis burden scale for adults: development and validation of a new assessment tool. Acta dermato-venereologica. 2015;95(6):700-705.
Foley C, Tundia N, Simpson E, Teixeira HD, Litcher-Kelly L, Bodhani A. Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: The Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS). Curr Med Res Opin. 2019;35(7):1139-1148.